Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Participants With Persistent Asthma
- Study Title
- Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
- Teva Identifier
- FSS-AS-30017 | 2014-000923-25
- ClinicalTrials.gov Identifier
- NCT02141854
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: FS MDPI | Drug: Fp MDPI | Drug: Placebo MDPI | Drug: Albuterol/salmeterol HFA MDI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 06/01/2014 - 09/01/2015
- Phase
- Phase 3
